|
The 2008 Diversity Summit
|
|
October 17, 2008 12:00 - 1:00 PM ET
|
Join FDA Commissioner Andrew von Eschenbach and the Diversity Council for the 4th Annual Diversity Summit.
This year’s theme is “Integrating New People and New Ideas.” The panel will focus on the agency’s growth, and the challenge of preserving the balance between our institutional knowledge, history and culture and the new ideas and perspectives that our new employees bring. A live question and answer session will follow the discussion.
NOTE: For FDA Employees Only.
For more information about this event, click here.
|
|
|
|
|
Overview of the Implementation of the Current Good Manufacturing Practices for Dietary Supplements Guidance for Industry
|
|
October 24, 2007 (3 hrs.)
|
This program discusses the new regulations and provides an opportunity for viewers to ask questions about them. The broadcast provides a
general introduction to the rule, the regulation as it applies to manufacturing, and other requirements in the rule. A very informative question and answer session follows the presentations.
Click here to view an archive of the webcast. Archived version will be available for one year from the original air date.
|
|
|
|
The Commissioner’s 2008 ORA All Hands
|
|
February 26, 2008 (1 hr.)
|
FDA Commissioner Andrew C. von Eschenbach invites ORA staff to a live all-hands broadcast that will address the challenges facing the
Agency and his priorities for the coming year. This will be an interactive discussion and will provide an opportunity for you to ask questions and share your point of view.
Click here to view an archive of the webcast. Archived version will be available for one year from the original air date.
|
|
|
|
Update on the Matrix
|
|
September 17, 2008 (1 hr.)
|
In this all-hands broadcast, moderated by Mark Barnett, Dr. Schultz will give an update on the Matrix and Dr. Jonathan Sackner-Bernstein,
the Center’s new Associate Director for Postmarket Programs, will discuss his vision and goals for the Matrix. A live question and answer session will follow the discussion.
|
|
|
|